These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37437466)

  • 21. Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve.
    Utsunomiya T; Shimada M; Hanaoka J; Kanamoto M; Ikemoto T; Morine Y; Imura S; Harada M
    J Gastroenterol; 2012 Apr; 47(4):470-6. PubMed ID: 22170416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Plasma Sampling Method to Determine the Hepatic and Renal Clearance of the 2 Diastereoisomers of Gd-EOB-DTPA.
    Yuan X; Wang S; Shi W; Cai Y; Chen Y; Chen M; Peng Y; Ao G
    Invest Radiol; 2020 Mar; 55(3):168-173. PubMed ID: 31917760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Remnant Liver Function Evaluation Using a Routine Clinical Dynamic Gd-EOB-DTPA-Enhanced MRI Protocol in Patients with Hepatocellular Carcinoma.
    Wang Y; Zhang L; Ning J; Zhang X; Li X; Zhang L; Chen G; Zhao X; Wang X; Yang S; Yuan C; Dong J; Chen H
    Ann Surg Oncol; 2021 Jul; 28(7):3672-3682. PubMed ID: 33230746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
    Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
    Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image Non-Uniformity Correction for 3-T Gd-EOB-DTPA-Enhanced MR Imaging of the Liver.
    Ogasawara G; Inoue Y; Matsunaga K; Fujii K; Hata H; Takato Y
    Magn Reson Med Sci; 2017 Apr; 16(2):115-122. PubMed ID: 27385553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure.
    Donadon M; Lanza E; Branciforte B; Muglia R; Lisi C; Pedicini V; Poretti D; Famularo S; Balzarini L; Torzilli G
    Surgery; 2020 Sep; 168(3):419-425. PubMed ID: 32600880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of type 2 diabetes on Gd-EOB-DTPA uptake into liver parenchyma: replication study in human subjects.
    Kumasaka S; Seki Y; Kumasaka Y; Tsushima Y
    Abdom Radiol (NY); 2021 Oct; 46(10):4682-4688. PubMed ID: 34164726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma? A Systematic Review with Meta-Analysis.
    Yinzhong W; Xiaoxue T; Jinhui T; Pengcheng Y; Xiaoying L; Junqiang L
    Curr Med Imaging; 2022; 18(6):633-647. PubMed ID: 34533447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.
    Araki K; Harimoto N; Kubo N; Watanabe A; Igarashi T; Tsukagoshi M; Ishii N; Tsushima Y; Shirabe K
    HPB (Oxford); 2020 Feb; 22(2):318-327. PubMed ID: 31477460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with Technetium-99m galactosyl serum albumin scintigraphy.
    Nishie A; Ushijima Y; Tajima T; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Takayama Y; Okamoto D; Abe K; Obara M; Yoshimitsu K; Honda H
    Eur J Radiol; 2012 Jun; 81(6):1100-4. PubMed ID: 21435811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion.
    Barth BK; Fischer MA; Kambakamba P; Lesurtel M; Reiner CS
    Eur J Radiol; 2016 Apr; 85(4):843-9. PubMed ID: 26971433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Li J; Wang J; Lei L; Yuan G; He S
    Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and
    Fabritius MP; Garlipp B; Öcal O; Puhr-Westerheide D; Amthauer H; Geyer T; Holzgreve A; Ricke J; Kupitz D; Grosser OS; Omari J; Pech M; Seidensticker M; Grawe F; Seidensticker R
    Eur Radiol Exp; 2024 Jan; 8(1):15. PubMed ID: 38282160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study.
    Kudo M; Gotohda N; Sugimoto M; Kobayashi S; Konishi M; Kobayashi T
    BMC Surg; 2023 Jun; 23(1):179. PubMed ID: 37370103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.